INKT
Price
$7.25
Change
-$0.30 (-3.97%)
Updated
Jun 13 closing price
Capitalization
28.9M
ORMP
Price
$2.12
Change
-$0.12 (-5.36%)
Updated
Jun 13 closing price
Capitalization
86.6M
59 days until earnings call
Interact to see
Advertisement

INKT vs ORMP

Header iconINKT vs ORMP Comparison
Open Charts INKT vs ORMPBanner chart's image
MiNK Therapeutics
Price$7.25
Change-$0.30 (-3.97%)
Volume$2.2K
Capitalization28.9M
Oramed Pharmaceuticals
Price$2.12
Change-$0.12 (-5.36%)
Volume$42.95K
Capitalization86.6M
INKT vs ORMP Comparison Chart
Loading...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INKT vs. ORMP commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INKT is a Hold and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (INKT: $7.25 vs. ORMP: $2.12)
Brand notoriety: INKT and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INKT: 59% vs. ORMP: 60%
Market capitalization -- INKT: $28.9M vs. ORMP: $86.6M
INKT [@Biotechnology] is valued at $28.9M. ORMP’s [@Biotechnology] market capitalization is $86.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INKT’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • INKT’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than INKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INKT’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 3 bullish TA indicator(s).

  • INKT’s TA Score: 4 bullish, 5 bearish.
  • ORMP’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, INKT is a better buy in the short-term than ORMP.

Price Growth

INKT (@Biotechnology) experienced а -0.07% price change this week, while ORMP (@Biotechnology) price change was -4.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

INKT is expected to report earnings on May 15, 2025.

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($86.6M) has a higher market cap than INKT($28.9M). INKT YTD gains are higher at: 4.032 vs. ORMP (-12.397). ORMP has higher annual earnings (EBITDA): 9.44M vs. INKT (-14.07M). ORMP has more cash in the bank: 142M vs. INKT (393K). ORMP has less debt than INKT: ORMP (429K) vs INKT (4.61M). INKT (0) and ORMP (0) have equivalent revenues.
INKTORMPINKT / ORMP
Capitalization28.9M86.6M33%
EBITDA-14.07M9.44M-149%
Gain YTD4.032-12.397-33%
P/E RatioN/A20.91-
Revenue00-
Total Cash393K142M0%
Total Debt4.61M429K1,075%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
79
PRICE GROWTH RATING
1..100
77
P/E GROWTH RATING
1..100
49
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INKTORMP
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 28 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
90%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FFMGF0.15N/A
+2.46%
First Mining Gold Corp.
UOVEF27.200.21
+0.79%
United Overseas Bank Ltd.
SCRYY3.260.01
+0.31%
SCOR
ACSAY12.94-0.26
-1.93%
ACS Actividades De Construccion Y Servicios SA
ALUR2.48-0.08
-3.12%
Allurion Technologies

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with RAIN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
-3.97%
RAIN - INKT
43%
Loosely correlated
+1.46%
LPTX - INKT
43%
Loosely correlated
-2.91%
ABCZF - INKT
33%
Loosely correlated
N/A
TERN - INKT
30%
Poorly correlated
-1.27%
ORMP - INKT
29%
Poorly correlated
-5.36%
More